TY - JOUR
T1 - Modulating Alginate Hydrogels for Improved Biological Performance as Cellular 3D Microenvironments
AU - Neves, Mariana Isabel
AU - Moroni, Lorenzo
AU - Barrias, Cristina Carvalho
N1 - Funding Information:
LM is grateful to the European Research Council starting grant Cell Hybridge (Grant #637308), the Dutch Province of Limburg, Progetto FISR - C.N.R. Tecnopolo di nanotecnologia e fotonica per la medicina di precisione (CUP B83B17000010001), and Tecnopolo per la medicina di Precisione - Regione Puglia (CUP: B84I18000540002). The authors would like to acknowledge FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 - Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020, and Portuguese funds through FCT - Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia e Ensino Superior in the framework of Project ANGIONICHE (POCI-01-0145-FEDER-028744 and PTDC/BTMMAT/28744/2017). The authors thank to FCT the doctoral grant SFRH/BD/129855/2017 to MN and the research position IF/00296/2015 to CB. Funding. Project ANGIONICHE (POCI-01-0145-FEDER-028744 and PTDC/BTMMAT/28744/2017), doctoral grant SFRH/BD/129855/2017 (MN), and research position IF/00296/2015 (CB).
Publisher Copyright:
© Copyright © 2020 Neves, Moroni and Barrias.
PY - 2020/6/30
Y1 - 2020/6/30
N2 - The rational choice and design of biomaterials for biomedical applications is crucial for successfulin vitroandin vivostrategies, ultimately dictating their performance and potential clinical applications. Alginate, a marine-derived polysaccharide obtained from seaweeds, is one of the most widely used polymers in the biomedical field, particularly to build three dimensional (3D) systems forin vitroculture andin vivodelivery of cells. Despite their biocompatibility, alginate hydrogels often require modifications to improve their biological activity, namely via inclusion of mammalian cell-interactive domains and fine-tuning of mechanical properties. These modifications enable the addition of new features for greater versatility and control over alginate-based systems, extending the plethora of applications and procedures where they can be used. Additionally, hybrid systems based on alginate combination with other components can also be explored to improve the mimicry of extracellular microenvironments and their dynamics. This review provides an overview on alginate properties and current clinical applications, along with different strategies that have been reported to improve alginate hydrogels performance as 3D matrices and 4D dynamic systems.
AB - The rational choice and design of biomaterials for biomedical applications is crucial for successfulin vitroandin vivostrategies, ultimately dictating their performance and potential clinical applications. Alginate, a marine-derived polysaccharide obtained from seaweeds, is one of the most widely used polymers in the biomedical field, particularly to build three dimensional (3D) systems forin vitroculture andin vivodelivery of cells. Despite their biocompatibility, alginate hydrogels often require modifications to improve their biological activity, namely via inclusion of mammalian cell-interactive domains and fine-tuning of mechanical properties. These modifications enable the addition of new features for greater versatility and control over alginate-based systems, extending the plethora of applications and procedures where they can be used. Additionally, hybrid systems based on alginate combination with other components can also be explored to improve the mimicry of extracellular microenvironments and their dynamics. This review provides an overview on alginate properties and current clinical applications, along with different strategies that have been reported to improve alginate hydrogels performance as 3D matrices and 4D dynamic systems.
KW - alginate
KW - biomaterial
KW - biofunctionalization
KW - 3D cell culture
KW - 4D systems
KW - MESENCHYMAL STEM-CELLS
KW - SPACER ARM LENGTH
KW - EXTRACELLULAR-MATRIX
KW - ADHESION LIGAND
KW - ISLET XENOTRANSPLANTATION
KW - SULFATED POLYSACCHARIDES
KW - COMPOSITE HYDROGELS
KW - SUBSTRATE STIFFNESS
KW - STRESS-RELAXATION
KW - PECTIN HYDROGELS
U2 - 10.3389/fbioe.2020.00665
DO - 10.3389/fbioe.2020.00665
M3 - (Systematic) Review article
C2 - 32695759
SN - 2296-4185
VL - 8
JO - Frontiers in bioengineering and biotechnology
JF - Frontiers in bioengineering and biotechnology
M1 - 665
ER -